WASHINGTON, D.C.—The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Hayat Onyuksel, Ph.D., Professor of Pharmaceutics and Bioengineering, Department of Biopharmaceutical Sciences, Department of Bioengineering, University of Illinois at Chicago, to its College of Fellows.
Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”
Dr. Onyuksel was nominated, reviewed, and elected by peers and members of the College of Fellows for “outstanding contributions to the development of safe and effective nanomedicines for targeted treatments of breast cancer and inflammatory diseases”